Biomarker

Researchers have recently identified common metabolites across cancer types like pancreatic and glioma cancer, suggesting their potential as universal cancer biomarkers.

  • This offers a non-invasive method for early cancer diagnosis and therapeutic strategies for cancer treatment.
  • About Biomarker: It is a biological molecule or characteristic that indicates a normal or abnormal process in the body. 

o It can be used to detect disease, monitor treatment, and predict the risk of developing disease. 

Need for Reliable Cancer Biomarkers:

o Aggressive cancers like pancreatic and glioma are often diagnosed late and have poor prognoses.

o Non-invasive biomarkers can address gaps in early cancer detection and treatment strategies.

    • Role of Nano Messengers (Exosomes): Exosomes, carriers of tumour-derived metabolites, provide insights into the tumour microenvironment (TME).
    o They help explore metabolic interactions within tumours, aiding in precise diagnosis and targeted therapies.